Skip to content
HowShorted

Inhibikase Therapeutics, Inc. short interest in 2026

In 2026, Inhibikase Therapeutics, Inc.'s disclosed short interest ran from 10.11% of shares outstanding on 15 Jan 2026 to 13.27% on 15 Sep 2026, a change of +3.16 percentage points. The year's high was 21.34% on 27 Feb 2026 and its low 10.11% on 15 Jan 2026, averaging 14.40% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 47.49 days on 15 Sep 2026. Full history: Inhibikase Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Inhibikase Therapeutics, Inc. in 2026

2026 in figures

Start of year
10.11% (15 Jan 2026)
End of year
13.27% (15 Sep 2026)
Change
+3.16 pp
High
21.34% (27 Feb 2026)
Low
10.11% (15 Jan 2026)
Average
14.40%
Highest days to cover
47.49 (15 Sep 2026)
SEC filings marked
6

Every report in 2026

Inhibikase Therapeutics, Inc. short interest in 2026
SettlementShort interestDays to coverFilings since previous
15 Jan 202610.11%14.69
30 Jan 202611.76%17.85
13 Feb 202614.02%12.48
27 Feb 202621.34%4.61
13 Mar 202621.33%11.91
31 Mar 202613.07%8.4210-K filed, results (8-K)
15 Apr 202613.47%19.25
30 Apr 202613.62%17.10
15 May 202613.40%26.5210-Q filed, results (8-K)
29 May 202614.02%24.57
15 Jun 202614.31%34.36
30 Jun 202614.71%17.38
15 Jul 202613.83%16.94
31 Jul 202614.49%21.49
14 Aug 202614.09%35.5310-Q filed, results (8-K)
31 Aug 202613.97%47.39
15 Sep 202613.27%47.49

See also: Inhibikase Therapeutics, Inc.'s full history · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.